Alex Zisson

Filings by Alex Zisson span 3 companies, the busiest being Auspex Pharmaceuticals, Inc., Clarus Therapeutics Holdings, Inc. and Ocera Therapeutics, Inc. Between 15 July 2013 and 9 September 2021, the trades on record add up to 16 filings.

Both buying and selling appear: 1 purchase worth €734k, against 2 sales worth €34.3M. The net balance comes to €33.6M on the selling side. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Besides market trades, the filings include 4 share grants and 3 option exercises.

On 13 September 2021 came the latest disclosure, a share grant in Clarus Therapeutics Holdings, Inc. The last purchase on record was published on 12 February 2014, which is 4,637 days ago. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 4 days. The legal deadline for a Form 4 is two business days after the transaction. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.